Neuronoff implanted its first patient in a DoD-funded trial of its Injectrode platform for neurogenic bladder in spinal cord injury. The Injectrode is an injectable electrode designed to deliver neuromodulation without implanted leads, reducing surgical burden. The first implant moves the platform from preclinical validation into human testing.